Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    June 2021
  1. DESHPANDE AA, Sharma V, Bansal R, Jagia P, et al
    Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade.
    Lancet. 2021;397:e15.
    PubMed    


    May 2021
  2. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    PubMed    


    April 2021
  3. WALTER KS, Martinez L, Arakaki-Sanchez D, Sequera VG, et al
    The escalating tuberculosis crisis in central and South American prisons.
    Lancet. 2021 Apr 8. pii: S0140-6736(20)32578.
    PubMed     Abstract available


    March 2021
  4. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    PubMed    


  5. LANE R
    Nicole Salazar-Austin: emerging tuberculosis-HIV research leader.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00587.
    PubMed    


    January 2021
  6. MACLEAN E, Bigio J, Singh U, Klinton JS, et al
    Global tuberculosis awards must do better with equity, diversity, and inclusion.
    Lancet. 2021;397:192-193.
    PubMed    


    September 2020
  7. BURKI T
    Inappropriate behaviour claims at Stop TB prompt review.
    Lancet. 2020;396:876.
    PubMed    


    August 2020
  8. BISSON GP, Bastos M, Campbell JR, Bang D, et al
    Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
    Lancet. 2020;396:402-411.
    PubMed     Abstract available


  9. MAYANJA-KIZZA H, Sekaggya-Wiltshire C, Kassa D
    Optimal therapy for multidrug-resistant tuberculosis and HIV.
    Lancet. 2020;396:363-365.
    PubMed    


    April 2020

  10. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
    PubMed     Abstract available


  11. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    PubMed    


    March 2020
  12. MARTINEZ L, Cords O, Horsburgh CR, Andrews JR, et al
    The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
    Lancet. 2020;395:973-984.
    PubMed     Abstract available


  13. SAHU S, Ditiu L, Lawson L, Ntoumi F, et al
    UN General Assembly tuberculosis targets: are we on track?
    Lancet. 2020;395:928-930.
    PubMed    


  14. CAMPBELL JR, Bastos ML
    No time to waste: preventing tuberculosis in children.
    Lancet. 2020;395:924-926.
    PubMed    


  15. LANE R
    Sean Wasserman: rising star in TB-HIV research and medicine.
    Lancet. 2020;395:941.
    PubMed    


  16. KIM HY, Heysell SK, Mpagama S, Marais BJ, et al
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:783.
    PubMed    


  17. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Challenging the management of drug-resistant tuberculosis - Authors' reply.
    Lancet. 2020;395:783-784.
    PubMed    


  18. GASKELL KM, Moore DAJ
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:782-783.
    PubMed    


    February 2020
  19. LANE R
    Hans Kluge: charismatic, new WHO Regional Director for Europe.
    Lancet. 2020;395:329.
    PubMed    


    November 2019
  20. VARO R, Bila R, Saavedra B, Sitoe A, et al
    Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula.
    Lancet. 2019;394:1651.
    PubMed    


    October 2019
  21. THE LANCET
    End the tuberculosis emergency: a promise is not enough.
    Lancet. 2019;394:1482.
    PubMed    


  22. RAY S, Anand K
    Reduce the delay in tuberculosis diagnosis in India.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32476.
    PubMed    


  23. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    PubMed    


    September 2019
  24. REUTER A, Hughes J, Furin J
    Challenges and controversies in childhood tuberculosis.
    Lancet. 2019;394:967-978.
    PubMed     Abstract available


  25. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Management of drug-resistant tuberculosis.
    Lancet. 2019;394:953-966.
    PubMed     Abstract available


  26. THE LANCET
    Tuberculosis needs accelerated and continued attention.
    Lancet. 2019;394:896.
    PubMed    


    August 2019
  27. REID MJA, Goosby E
    A tuberculosis-free world: is it a delusion? - Authors' reply.
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31411.
    PubMed    


  28. ATRE S
    A tuberculosis-free world: is it a delusion?
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31623.
    PubMed    


    July 2019
  29. BASHAM CA, Elias B, Orr P
    Tuberculosis elimination in Canada.
    Lancet. 2019;394:300-301.
    PubMed    


  30. MENZIES D, Benedetti A, Migliori GB, Nahid P, et al
    Multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2019;394:299-300.
    PubMed    


  31. CHIANG CY, Van Deun A, Trebucq A, Piubello A, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:299.
    PubMed    


  32. CAMINERO JA, Garcia-Basteiro AL, Rendon A
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298.
    PubMed    


  33. NYANG'WA BT, Berry C, Fielding K, Nunn AJ, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298-299.
    PubMed    


    May 2019
  34. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    PubMed    


    March 2019
  35. ZUCCALA E, Horton R
    Time to bring tuberculosis out of the shadows.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30486.
    PubMed    


  36. KI-MOON B
    Building a tuberculosis-free world on a foundation of universal health coverage.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30433.
    PubMed    


  37. ZAROCOSTAS J
    Nandita Venkatesan: a voice of hope for tuberculosis survivors.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30582.
    PubMed    


  38. NADDA JP
    India's leadership to end tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30487.
    PubMed    


  39. KUMAR A
    Picturing health: it's time to act on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30583.
    PubMed    


  40. WEBSTER P
    Inuit research raises concerns about tuberculosis eradication.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30681.
    PubMed    


  41. REID MJA, Arinaminpathy N, Bloom A, Bloom BR, et al
    Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30024.
    PubMed    


  42. FURIN J, Cox H, Pai M
    Tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30308.
    PubMed     Abstract available


  43. WATTS G
    Christine Sekaggya-Wiltshire: prizewinner in HIV-tuberculosis research.
    Lancet. 2019 Mar 19. pii: S0140-6736(19)30644.
    PubMed    


  44. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    PubMed     Abstract available


    February 2019
  45. STORY A, Aldridge RW, Smith CM, Garber E, et al
    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
    Lancet. 2019 Feb 21. pii: S0140-6736(18)32993.
    PubMed     Abstract available


  46. FRASER H, Keshavjee S
    Video-observed therapy for tuberculosis: strengthening care.
    Lancet. 2019 Feb 21. pii: S0140-6736(19)30293.
    PubMed    


    January 2019
  47. FERRY G
    Dorothy Stopford Price and the control of tuberculosis in Ireland.
    Lancet. 2019;393:20.
    PubMed    


    November 2018
  48. GRANICH R
    Is the global tuberculosis control strategy too big to fail?
    Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
    PubMed    


    October 2018
  49. COUSINS S
    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    PubMed    


    September 2018
  50. MARAIS B, Zumla A
    Advancing global tuberculosis control after the UNGA-HLM.
    Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
    PubMed    


  51. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Abstract available


  52. FARMER PE
    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    PubMed    


  53. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    PubMed    


    August 2018
  54. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed    


    July 2018
  55. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Abstract available


  56. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed    


    May 2018
  57. CHATTOPADHYAY A, Sharma A, Gupta K, Jain S, et al
    The Phemister triad.
    Lancet. 2018;391:e20.
    PubMed    


  58. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed    


    April 2018
  59. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed    


    March 2018
  60. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed    


  61. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed    


  62. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed    


  63. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed    


  64. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed    


  65. THE LANCET
    The Global Fund under Peter Sands.
    Lancet. 2018;391:912.
    PubMed    


    January 2018
  66. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed    


    September 2017
  67. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed    


  68. COX H, Reuter A, Furin J, Seddon J, et al
    Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
    Lancet. 2017;390:934.
    PubMed    


    June 2017
  69. VENKATESH P
    Tuberculosis in India: health policy alone is not enough.
    Lancet. 2017;389:2471.
    PubMed    


  70. PAI M, Jha P
    Tuberculosis in India: health policy alone is not enough - Authors' reply.
    Lancet. 2017;389:2471-2472.
    PubMed    


    March 2017
  71. SHARMA DC
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    PubMed    


  72. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    PubMed    


  73. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    PubMed    


    February 2017
  74. SHARMA DC
    India plans to expand access to new tuberculosis drug.
    Lancet. 2017;389:685.
    PubMed    


  75. COUSINS S
    Myanmar grapples with its high tuberculosis burden.
    Lancet. 2017;389:491-492.
    PubMed    


    January 2017
  76. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Abstract available


    November 2016
  77. CARRUTH L, Roess AA, Mekonnen YT, Melaku SK, et al
    Zoonotic tuberculosis in Africa: challenges and ways forward.
    Lancet. 2016;388:2460-2461.
    PubMed    


  78. BERRY C, Achar J, du Cros P
    WHO recommendations for multidrug-resistant tuberculosis.
    Lancet. 2016;388:2234.
    PubMed    


  79. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2016;388:2234-2235.
    PubMed    


  80. ZAK D, Scriba TJ, Hatherill M, Penn-Nicholson A, et al
    Predicting tuberculosis risk - Authors' reply.
    Lancet. 2016;388:2233-2234.
    PubMed    


  81. KIK SV, Cobelens F, Moore D
    Predicting tuberculosis risk.
    Lancet. 2016;388:2233.
    PubMed    


    October 2016
  82. NADDA JP, Singh PK
    New evidence of the tuberculosis burden in Asia demands national action.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31853.
    PubMed    


  83. ALDRIDGE RW, Zenner D, White PJ, Williamson EJ, et al
    Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
    Lancet. 2016 Oct 10. pii: S0140-6736(16)31008.
    PubMed     Abstract available


  84. REINL J
    UN declaration on antimicrobial resistance lacks targets.
    Lancet. 2016;388:1365.
    PubMed    


  85. CHEN S, Zhang H, Qu Y, Wu Y, et al
    Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S88.
    PubMed     Abstract available


  86. GAO L, Bai L, Liu J, Lu W, et al
    Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.
    Lancet. 2016;388 Suppl 1:S16.
    PubMed     Abstract available


    July 2016
  87. FEDER HM JR, Rigos L, Teti K
    Pott's disease in a Connecticut toddler.
    Lancet. 2016;388:504.
    PubMed    


  88. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: